| Drug NDC: | 62795-9491 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. | |
| Proprietary Name: | Lymphomyosot |
| Also known as the trade name. It is the name of the product chosen by the labeler. | |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. | |
| Non Proprietary Name: | Araneus Diadematus, Tribasic Calcium Phosphate,equisetum Hyemale Whole, Ferrous Iodide,fumaria Officinalis Flowering Top, Gentiana Lutea Root, Juglans Regia Leaf, Levothyroxine Sodium Anhydrous, Myosotis Arvensis Whole,nasturtium Officinale,sodium Sulfate, Pinus Sylvestris Leafy Twig,smilax Ornata Root,scrophularia Nodosa Whole, Teucrium Scorodonia Flowering, Veronica Officinalis Flowering Top |
| Also known as the generic name, this is usually the active ingredient(s) of the product. | |
| Labeler Name: | Medinatura Inc |
| Name of Company corresponding to the labeler code segment of the ProductNDC. | |
| Dosage Form: | Tablet |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. | |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. | |
| Substance Name: | ARANEUS DIADEMATUS - 6 [hp_X]/1 EQUISETUM HYEMALE WHOLE - 4 [hp_X]/1 FERROUS IODIDE - 12 [hp_X]/1 FUMARIA OFFICINALIS FLOWERING TOP - 4 [hp_X]/1 GENTIANA LUTEA ROOT - 5 [hp_X]/1 GERANIUM ROBERTIANUM - 4 [hp_X]/1 JUGLANS REGIA LEAF - 3 [hp_X]/1 LEVOTHYROXINE SODIUM ANHYDROUS - 12 [hp_X]/1 MYOSOTIS ARVENSIS WHOLE - 3 [hp_X]/1 NASTURTIUM OFFICINALE - 4 [hp_X]/1 Load more... PINUS SYLVESTRIS LEAFY TWIG - 4 [hp_X]/1 SCROPHULARIA NODOSA WHOLE - 3 [hp_X]/1 SMILAX ORNATA ROOT - 6 [hp_X]/1 SODIUM SULFATE - 4 [hp_X]/1 TEUCRIUM SCORODONIA FLOWERING TOP - 3 [hp_X]/1 TRIBASIC CALCIUM PHOSPHATE - 12 [hp_X]/1 VERONICA OFFICINALIS FLOWERING TOP - 3 [hp_X]/1 |
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. | |
| Route Details: | ORAL |
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. | |
| Marketing Category: | UNAPPROVED HOMEOPATHIC |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. | |
| Marketing Start Date: | 16 Feb, 2022 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. | |
| Marketing End Date: | 06 May, 2026 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. | |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. | |
| Manufacturer Name: | MediNatura Inc |
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. | |
| Original Packager: | Yes |
| Whether or not the drug has been repackaged for distribution. | |
| UNII: | 6T6CO7R3Z5 59677RXH25 F5452U54PN VH659J61ZL S72O3284MS R5I1HK0UBL 85HKB87105 054I36CPMN C73BK97H5J YH89GMV676 Load more... Q1RGP4UB73 7H443NUB2T 2H1576D5WG 0YPR65R21J LOK3I16O7G 91D9GV0Z28 9IH82J936J |
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. | |
| Pharmacologic Class: | Blood Coagulation Factor [EPC] Calcium [CS] Cations Divalent [CS] Increased Coagulation Factor Activity [PE] Thyroxine [CS] l-Thyroxine [EPC] |
| These are the reported pharmacological class categories corresponding to the SubstanceNames listed above. | |
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|---|---|---|---|
| 62795-9491-2 | 1 BOTTLE in 1 CARTON (62795-9491-2) / 100 TABLET in 1 BOTTLE | 16 Feb, 2022 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. | ||||
* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.